You need to provide
This test is for
What is CA15.3?
This assay is useful for predicting early recurrence in women treated for Carcinoma Breast. It is specially useful for serial testing in women with prior Stage II / III breast cancer who are clinically free of disease.
Diagno Labs, established in the year 2012, is uniquely positioned to more effectively support local pathology for enhanced patient care. Diagno Labs, with complementary areas of expertise and service offerings, allows us to build on the company's leadership positions, provide access to medical and scientific expertise, expand geographical presence to better serve customers and emerge as the most valued company in the healthcare industry. Our Parent group RJ Corp is a well-diversified Indian...